Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease
International Immunology · 2023
DOI: 10.1093/intimm/dxad018 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2023. Verfasst von Yuki Tai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Immunology, Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, …. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: JSPS, Hamaguchi Foundation, Astellas Foundation for Research on Metabolic Disorders.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a common chronic skin disease caused by immune dysfunction, specifically the hyperactivation of Th2 immunity. AD is a complex disease with multiple factors contributing to its development; however, the interaction between these factors is not fully understood. In this study, we demonstrated that the conditional deletion of both the forkhead box p3 (Foxp3) and B-cell lymphoma 6 (Bcl6) genes induced the spontaneous development of AD-like skin inflammation with hyperactivation of type 2 immunity, skin barrier dysfunction, and pruritus, which were not induced by the single deletion of each gene. Furthermore, the development of AD-like skin inflammation was largely dependent on IL-4/13 signaling but not on immunoglobulin E (IgE). Interestingly, we found that the loss of Bcl6 alone increased the expression of thymic stromal lymphopoietin (TSLP) and interleukin (IL)-33 in the skin, suggesting that Bcl6 controls Th2 responses by suppressing TSLP and IL-33 expression in epithelial cells. Our results suggest that Foxp3 and Bcl6 cooperatively suppress the pathogenesis of AD. Furthermore, these results revealed an unexpected role of Bcl6 in suppressing Th2 responses in the skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Immunology, Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
- Laboratory of Molecular Medical Science, Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
- Division of Immunology, Health Science Faculty, International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component & Institute of Infectious Diseases and Molecular Medicine (IDM), University of…
- Division of Integrated Research, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba 278-0022, Japan.
ORCID-Profile: Yohsuke Harada
Förderung
- JSPS
- Hamaguchi Foundation
- Astellas Foundation for Research on Metabolic Disorders
Zitieren
APA
Tai, Y., Sakaida, Y., Kawasaki, R., Kanemaru, K., Akimoto, K., Brombacher, F., Ogawa, S., Nakamura, Y., & Harada, Y. (2023). Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease. International Immunology. https://doi.org/10.1093/intimm/dxad018
Vancouver
Tai Y, Sakaida Y, Kawasaki R, Kanemaru K, Akimoto K, Brombacher F, et al. Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease. International Immunology. 2023. doi:10.1093/intimm/dxad018
BibTeX
@article{Tai2023,
author = {Tai, Yuki and Sakaida, Yuki and Kawasaki, Riyo and Kanemaru, Kaori and Akimoto, Kazunori and Brombacher, Frank and Ogawa, Shuhei and Nakamura, Yoshikazu and Harada, Yohsuke},
title = {Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease},
journal = {International Immunology},
year = {2023},
doi = {10.1093/intimm/dxad018}
}
EUVIMED